Mostrar filtros
Tipo de recursos
Filtrar por Tipo de recursos
Patologias
Filtrar por Patologias
Tecnologias
Filtrar por Tecnologias
Instrumentos
Filtrar por Instrumentos
71 Resultado(s) encontrado(s)
Ordenar por:

Sebia receives U.S. FDA Clearance for the FLC Kappa & Lambda assays

Comunicado de Imprensa
Mar. 07, 2024

Expanding offering for Multiple Myeloma and AL Amyloidosis Testing.

How External Quality Assessment supports quality improvement in laboratory hemoglobinopathy diagnosis

Webinar
Fev. 21, 2024

Educational Workshop with Dr. Barbara De la Salle

HYDRASYS 2 SCAN FOCUSING: Overview

Vídeo
Fev. 13, 2024

Learn more about the HYDRASYS 2 SCAN FOCUSING for a fast and user-friendly gel electrophoresis processing.

Autoinmunidad y cáncer : Cruce de caminos en la disregulación del sistema inmunitario

Webinar
Dez. 15, 2023

Autoinmunidad y Cáncer : aproximación inteligente al diagnóstico y tratamiento de enfermedades derivadas de las células plasmáticas

Sebia launches M-inSight®, a test for monitoring multiple myeloma patients

Comunicado de Imprensa
Dez. 04, 2023

Corgenix, a Sebia Group company, CAP/CLIA clinical laboratory, positions Sebia to globally commercialize M-inSight®, a novel non-invasive liquid biopsy assay for Minimal Residual Disease (MRD) monitoring in multiple myeloma

Dez. 09, 2023 Dez. 11, 2023

Evento
San Diego, CA

ASH 2023

Sebia booth: #2455

Saber mais

Current Status of Detecting Monoclonal Antibodies and Free Light Chains in Serum

Webinar
Ago. 31, 2023

Educational Webinar with Dr. Matthias Orth from University of Heidelberg at University Hospital Mannheim.

Set. 21, 2023 Set. 23, 2023

Evento
Porto, Portugal

PAM 2023

 

Saber mais